During the past decade, Peninsula Private Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 3 clinical trials were completed, i.e. on average, 21.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peninsula Private Hospital" #1 sponsor was "BeiGene" with 7 trials, followed by "Loxo Oncology, Inc." with 2 trials sponsored, "Bayside Health" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Calithera Biosciences, Inc" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peninsula Private Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Ambulance Victoria" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Baker Heart and Diabetes Institute" with 1 trials as a collaborator and "FALCK Foundation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Peninsula Private Hospital" are "Chronic Lymphocytic Leukemia" (4 trials), "Small Lymphocytic Lymphoma" (4 trials), "B-cell Malignancies" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Advanced Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Peninsula Private Hospital" in a lesser frequency.

Most popular intervention types in "Peninsula Private Hospital" are "Drug" (14 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zanubrutinib" (6 trials), "Placebo" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials) and "Pirtobrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Private Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Peninsula Private Hospital". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Peninsula Private Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Private Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".